Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD0RQ
|
||||
| Drug Name |
4-Methyl-2-(4'-morpholin-2-yl-biphenyl-3-yl)-pentanoic acid cyanomethyl-amide
|
||||
| Synonyms |
CHEMBL333716
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H29N3O2
|
||||
| Canonical SMILES |
CC(C)CC(C(=O)NCC#N)c1cccc(c1)c2ccc(cc2)C3CNCCO3
|
||||
| InChI |
InChI=1S/C24H29N3O2/c1-17(2)14-22(24(28)27-11-10-25)21-5-3-4-20(15-21)18-6-8-19(9-7-18)23-16-26-12-13-29-23/h3-9,15,17,22-23,26H,11-14,16H2,1-2H3,(H,27,28)
|
||||
| InChIKey |
DSOZMZYFXRHZGI-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.